Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Shopify
SHOP
|
+$382M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$254M |
| 3 |
American Electric Power
AEP
|
+$224M |
| 4 |
Goldman Sachs
GS
|
+$215M |
| 5 |
Baidu
BIDU
|
+$212M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.28B |
| 2 |
Microsoft
MSFT
|
+$1.46B |
| 3 |
Intel
INTC
|
+$993M |
| 4 |
NVIDIA
NVDA
|
+$585M |
| 5 |
Meta Platforms (Facebook)
META
|
+$556M |
Sector Composition
| 1 | Technology | 17.5% |
| 2 | Healthcare | 13.64% |
| 3 | Consumer Discretionary | 11.41% |
| 4 | Financials | 10.82% |
| 5 | Industrials | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PARAA
2001
DELISTED
Paramount Global Class A
PARAA
| $5.08M | ﹤0.01% |
107,590
-113,398
| -51% | -$5.35M |
|
2002
Cartesian Therapeutics
RNAC
$252M
| $5.07M | ﹤0.01% |
37,378
+16,177
| +76% | +$2.2M |
|
2003
Waste Management
WM
$87.9B
| $5.07M | ﹤0.01% |
39,297
+5,770
| +17% | +$744K |
|
|
VRAY
2004
DELISTED
ViewRay, Inc.
VRAY
| $5.07M | ﹤0.01% |
1,164,439
-805,339
| -41% | -$3.5M |
|
|
PACXU
2005
DELISTED
Pioneer Merger Corp. Unit
PACXU
| $5.06M | ﹤0.01% |
+506,490
| New | +$5.06M |
|
2006
Tanger
SKT
$3.86B
| $5.05M | ﹤0.01% |
333,741
+109,960
| +49% | +$1.66M |
|
|
WARR.U
2007
DELISTED
Warrior Technologies Acquisition Company Units,eachconsistingofoneshare ofClassAcommonstockandone-halfofone warrant
WARR.U
| $5.05M | ﹤0.01% |
+510,000
| New | +$5.05M |
|
2008
Cable One
CABO
$968M
| $5.04M | ﹤0.01% |
2,757
+1,931
| +234% | +$3.53M |
|
2009
Patterson-UTI
PTEN
$2.13B
| $5.04M | ﹤0.01% |
706,977
-1,873,383
| -73% | -$13.4M |
|
2010
TTM Technologies
TTMI
$4.83B
| $5.04M | ﹤0.01% |
347,411
-362,715
| -51% | -$5.26M |
|
2011
Anika Therapeutics
ANIK
$125M
| $5.03M | ﹤0.01% |
123,326
+99,036
| +408% | +$4.04M |
|
|
CNCE
2012
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $5.03M | ﹤0.01% |
1,007,240
+116,987
| +13% | +$584K |
|
2013
Vanguard Total Bond Market
BND
$135B
| $5.02M | ﹤0.01% |
59,300
-134,350
| -69% | -$11.4M |
|
2014
LG Display
LPL
$4.46B
| $5.02M | ﹤0.01% |
502,907
+379,858
| +309% | +$3.79M |
|
|
VLTA
2015
DELISTED
Volta Inc.
VLTA
| $5.02M | ﹤0.01% |
458,144
-865,758
| -65% | -$9.48M |
|
|
FARO
2016
DELISTED
Faro Technologies
FARO
| $5.01M | ﹤0.01% |
57,918
-51,898
| -47% | -$4.49M |
|
2017
Sapiens International
SPNS
$2.4B
| $5M | ﹤0.01% |
157,189
-7,657
| -5% | -$243K |
|
2018
Navient
NAVI
$1.28B
| $4.99M | ﹤0.01% |
348,843
-548,833
| -61% | -$7.85M |
|
2019
Establishment Labs
ESTA
$1.09B
| $4.99M | ﹤0.01% |
79,768
+71,308
| +843% | +$4.46M |
|
2020
Standard BioTools
LAB
$493M
| $4.98M | ﹤0.01% |
1,102,574
-560,513
| -34% | -$2.53M |
|
|
VG
2021
DELISTED
Vonage Holdings Corporation
VG
| $4.98M | ﹤0.01% |
421,069
-497,834
| -54% | -$5.88M |
|
2022
Sinclair Inc
SBGI
$972M
| $4.97M | ﹤0.01% |
169,786
-12,935
| -7% | -$378K |
|
2023
Sonoco
SON
$4.71B
| $4.97M | ﹤0.01% |
78,473
+24,196
| +45% | +$1.53M |
|
|
JIH
2024
DELISTED
Juniper Industrial Holdings, Inc.
JIH
| $4.96M | ﹤0.01% |
400,314
-1,140,857
| -74% | -$14.1M |
|
2025
Kymera Therapeutics
KYMR
$3.36B
| $4.96M | ﹤0.01% |
+127,727
| New | +$4.96M |
|